期刊文献+

2型糖尿病肾病的危险因素分析 被引量:18

Analysis of risk factors for diabetic nephropathy in patients with type-two diabetes mellitus
下载PDF
导出
摘要 目的探讨糖尿病肾病(diabetic nephropathy,DN)发生的危险因素。方法对381例2型糖尿病患者根据尿白蛋白排泄率(urinary albumin excretion rate,UAER)分为3组:正常白蛋白尿(normal albuminuria,NA)组、微量白蛋白尿(microalbuminuria,MA)组、临床白蛋白尿(clinical proteinuria,CP)组。比较3组患者年龄、糖尿病病程、收缩压(systolic blood pressure,SBP)、舒张压(diastolic blood pressure,DBP)、腰臀比(waist-to-hip ratio,WHR)、体质量指数(body mass index,BMI)、空腹血糖(fasting plasmaglucose,FPG)、糖化血红蛋白(glycosylated hemoglobin,HbA1c)、三酰甘油(triglyceride,TG)、胆固醇(total cholesterol,TC)、高密度脂蛋白(high-density lipoprotein cholesterol,HDL-C)、低密度脂蛋白(low density lipoprotein cholesterol,LDL-C)、尿酸(uric acid,UA)以及空腹C肽(fasting blood C-peptide,C-P)等指标。采用Logistic回归分析DN与各因素的相关性。结果年龄、病程、WHR、SBP、DBP、LDL-C、TC、HbA1c、C肽、UA等指标在各组间的差异均有统计学意义(P<0.05)。Logistic回归分析结果显示,病程、SBP是DN的独立危险因素(OR值分别为1.029、1.088,P值均小于0.05)。结论 DN的发生及其严重程度与糖尿病病程及SBP独立相关,重视对DN相关因素的监测与评价有助于DN的预防和治疗。 Objective To study the relationship between diabetic nephropathy(DN) and its risk factors.Methods A total of 381 type-2 diabetic patients were divided into three groups: normal albuminuria(NA),microalbuminuria(MA) and clinical proteinuria(CP),depending on the levels of urinary albumin excretion rate(UAER).The differences of the 3 groups in terms of age,duration of diabetes,systolic blood pressure(SBP),diastolic blood pressure(DBP),waist-to-hip ratio(WHR),body mass index(BMI),fasting plasma glucose(FPG),glycosylated hemoglobin A1c(HbA1c),triglyceride(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C),uric acid(UA) and C-peptide.Logistic regression analysis was used to analyze the possible factors that might affect the DN.Results There were statistically significant differences in age,duration of diabetes,WHR,SBP,DBP,LDL-C,TC,HbA1c C-peptide and UA among the 3 groups.Logistic regression analysis showed that diabetic duration and SBP were independent risk factors(OR=1.029 and 1.088,P0.05 for both).Conclusion A close correlation has been found between duration of diabetes and SBP.Monitoring and evaluating systemic factors will be helpful for prevention and treatment of DN.
出处 《首都医科大学学报》 CAS 北大核心 2011年第5期605-608,共4页 Journal of Capital Medical University
基金 北京市卫生系统高层次卫生技术人才培养计划资助(2009-3-34) 首都医学发展基金(2005-20082009-Z-SQ03)~~
关键词 2型糖尿病 糖尿病肾病 危险因素 type-2 diabetes diabetic nephropathy risk factors
  • 相关文献

参考文献10

  • 1中华医学会糖尿病学分会慢性并发症调查组.1991~2000年全国住院糖尿病患者慢性并发症及相关大血管病变回顾性分析[J].中国医学科学院学报,2002,24(5):447-451. 被引量:263
  • 2Czekalski S.Diabetic nephropathy and cardiovascular disease[J].Rocz Akad Med Bialymst,2005,50:122-125.
  • 3孙蔚,高鑫,刘智慧,夏其昌.C肽对链脲佐菌素糖尿病大鼠的糖尿病肾病的干预作用[J].中华内分泌代谢杂志,2003,19(2):143-144. 被引量:18
  • 4The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus.Diabetes control and complications trial research group[J].N Engl J Med,1993,329(14):977-986.
  • 5Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS33) UK prospective diabetes study(UKPDS) group[J].Lancet,1998,352(9131):837-853.
  • 6Chen H C,Guh J Y,Shin S J,et al.Insulin and heparin supress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein[J].Kidney Int Suppl,2001,78:S124-S127.
  • 7Tonelli M,Moyé L,Sacks F M,et al.Effect of pravastain on loss of renal function in people with moderate chronicrenal insuffciency and cardiovascular disease[J].J Am Soc Nephrol,2003,14(6):1605-1613.
  • 8Nelaj E,Gjata M,Lilaj I,et al.Factors of cardiomascular risk in patients with type 2 diabetes and incipient nephropathy[J].Hippokratia,2008,12(4):221-224.
  • 9Feig D I,Kang D H,Johnson R J.Uric acid and cardiovascular risk[J].N Engl Med,2008,359 (17):1811-1821.
  • 10王俊杰,朱苏红,刘梅芳,刘文彦.尿酸与心肾疾病危险[J].四川生理科学杂志,2009,31(3):122-124. 被引量:8

二级参考文献26

  • 1全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-678.
  • 2Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk [J]. N Engl J Med, 2008, 359(17): 1811-1121.
  • 3Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome[J]. Cleve Clin J Med, 2006, 73(12): 1059-1064.
  • 4Wheeler JG, Juzwishin KD, Eiriksdottir G, et al. Serum uric acid and coronary heart disease in 9,458 incident eases and 155,084 controls: prospective study and meta-analysis[J]. PloSMed, 2005, 2 (3): e76.
  • 5Nieto FJ, Iribarren C, Gross MD, et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis[J]. Atheroselerosis, 2000, 148(1): 131-139.
  • 6Niskanen L, Laaksonen DE, Lindstr m J, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study [J]. Diabetes Care, 2006, 29(3): 709-711.
  • 7Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial[J]. JAMA, 2008, 300(8): 924-932.
  • 8Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men[J]. J Am Soc Nephrol, 2007, 18 (1): 287-292.
  • 9Krishnan E, Kwoh CK, Schumaeher HR, et al. Hyperurieemia and incidence of hypertension among men without metabolic syndrome[J]. Hypertension, 2007, 49(2): 298-303.
  • 10Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperurieemia with allopurinol on blood pressure, ereatinine clearence, and proteinuria in patients with normal renal funetions[J]. Int Urol Nephrol, 2007, 39(4) : 1227-1233.

共引文献286

同被引文献227

引证文献18

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部